Download the Press Release (PDF)
CHICAGO, USA – 7 July, 2023 –
For the ninth year in a row, The Journal of Heart and Lung Transplantation
’s Impact Factor earned the publication the number one ranking in the transplantation category. JHLT
ranks 7th in Surgery and 8th in Respiratory, and came in 19th in the highly competitive Cardiac & Cardiovascular Systems category.
’s overall 2022 Impact Factor is 8.9. The Impact Factor is published in the annual Journal Citation Reports (JCR), and is determined by the number of 2022 citations accumulated for JHLT
manuscripts published in the previous two years.
“I’m proud of this achievement by the Journal
, and must give credit to JHLT
’s staff, editors, and authors, and especially to past Editor-in-Chief Daniel R. Goldstein for his recent leadership of the Journal
,” said Michelle Kittleson, MD, PhD
, Interim Editor-in-Chief of JHLT
and Director of Postgraduate Education in Heart Failure and Transplantation and Professor of Medicine in the Smidt Heart Institute at Cedars-Sinai in Los Angeles, CA USA. “Our goal is for JHLT
to publish cutting-edge studies that move the fields of thoracic transplantation, mechanical circulatory support, pulmonary arterial hypertension, and lung transplantation forward. We encourage authors to continue to submit their best work to the Journal
, and will continue to publish impactful studies in these fields.”
had 14,893 citations in 2022. The Article Influence Score, a measure of how much attention a JHLT
paper would acquire when normalized for various categories, continues to rise, ranking 3.265 over last year’s score of 3.132. Any score over 1.00 indicates each article has above-average influence.
is the official publication of the International Society for Heart and Lung Transplantation (ISHLT). ISHLT is the only international interdisciplinary organization focused on interventions for advanced heart and lung disease, including transplantation.
The official publication of the International Society for Heart and Lung Transplantation, the Journal of Heart and Lung Transplantation brings readers essential scholarly and timely information in the field of cardiopulmonary transplantation, mechanical and biological support of the failing heart, advanced lung disease (including pulmonary vascular disease) and cell replacement therapy. Importantly, the Journal also serves as a medium of communication of pre-clinical sciences in all these rapidly expanding areas. For more information, visit www.jhltonline.org.
The International Society for Heart and Lung Transplantation is a not-for-profit, multidisciplinary professional organization dedicated to improving the care of patients with advanced heart or lung disease through transplantation, mechanical support and innovative therapies. With more than 3,800 members in more than 45 countries, ISHLT is the world’s largest organization dedicated to the research, education and advocacy of end-stage heart and lung disease. ISHLT members represent more than 15 different professional disciplines. For more information, visit www.ishlt.org.